Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia

Neurosci Lett. 2016 Sep 19:631:24-29. doi: 10.1016/j.neulet.2016.08.007. Epub 2016 Aug 10.

Abstract

Frontotemporal dementia (FTD) presents clinically with behavioral changes including disinhibition. Mutations in the tau-encoding MAPT gene identified in familial cases of FTD have been used to generate transgenic mouse models of the human condition. Here, we report behavioral changes in a recently developed P301S mutant tau transgenic mouse, including disinhibition-like behavior in the elevated plus maze and hyperactivity in the open field arena. Furthermore, histological analysis revealed the amygdala as a primary and early site of pathological tau deposition in these mice. Taken together, neuropathological and behavioral changes in P301S tau transgenic mice resemble features of human FTD.

Keywords: Behavior; Frontotemporal dementia; Tau; Transgenic mouse model.

MeSH terms

  • Amygdala / metabolism
  • Animals
  • Anxiety / genetics
  • Behavior, Animal / physiology*
  • Disease Models, Animal
  • Frontotemporal Dementia / genetics*
  • Frontotemporal Dementia / psychology*
  • Humans
  • Hyperkinesis / genetics
  • Male
  • Mice
  • Mice, Transgenic
  • Motor Activity
  • Mutation
  • tau Proteins / genetics*
  • tau Proteins / metabolism

Substances

  • MAPT protein, human
  • tau Proteins